Catalyst Wire Dossier Catalyst Wire Dossier

ropivacaine 0.2% + placebo

ropivacaine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ropivacaine 0.2% + placebo, covering 2020-03-12 to 2020-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block [Phase 4]

See pricing